BICO commercialized the first bio-based ink in 2016 but has since moved far beyond bioprinting and on-demand biofabrication of human organs and tissues. Last year the company reflected that evolution by changing its name from CELLINK Life Sciences to BICO, short for “bioconvergence”—a combination of biology, engineering and computer science technologies for healthcare and life-sci applications that include robotics, artificial intelligence, advanced genomics and bioprinting . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge